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Abstract 
Ureaplasma urealyticum has been one of the most prominent mucosal 
pathogens having many tropisms in humans. This pathogen is most 
notable for its high gene density in its genome i.e. the genes, more than 
600, encode almost 95% of the genome, which is suggestive of the fact 
that it has dispensed with many regulatory and biosynthetic genes for 
many metabolites and nutrients. By evolution, transporters have either 
substituted other genes or have duplicated themselves into paralogous 
Page 1 of 25The Transportome of the Human Mucosal Pathogen Ureaplasma urealyticum
8/31/2007http://www.lurj.org/article.php/vol2n1/ureaplasma.xml
members in Ureaplasma. SwissProt analysis and Transporter classification 
database were used to identify 67 open reading frames which represented 
the transporter dataset proteins from the whole genome. By this method, 
we identified a total of 20 transporters for haeme and/or iron (inclusive of 
binding and membrane subunits), 7 for inorganic cations (3 for Co2+, and 
one each for Mg2+, Cu2+, Ca2+ and K+), 11 for protons/ions, 5 for 
oligopeptides, 2 for amino acids, 2 for ammonium generated by urea 
hydrolysis, 4 for spermidine-putrescine, 4 for inorganic phosphate, 4 for 
sugars, and 2 belonging to the MOP (Multidrug-Oligosaccharidyl-lipid-
Polysaccharide Flippase Superfamily) MATE (Mullti drug and Toxin 
Extrusion) class of membrane proteins. In addition, there are 6 other 
transporters, among which 5 belong to the ABC transporter family which 
translocate unidentified substrates. Two groups of paralogous iron 
transporters were identified by phylogenetic analysis using PHYLIP. 
Conserved residues and domains in individual transporter families were 
obtained by using Pro Dom and Pfam databases. In order to incorporate 
the missing transporters of Ureaplasma urealyticum in our work, we have 
also included the studies relating to the possibility of finding 
transmembrane-signature bearing proteins from among the hypothetical 
proteins. With this end in sight, we have utilized 5 different tools (TMHMM, 
SOSUI, HMMTOP, TopPred, and waveTM) to estimate the probable 
transporter proteins. Each of these tools follows completely different 
algorithms. Since these tools are prone to errors mainly as a result of false 
predictions of signal peptides as transmembrane segments, we have 
utilized an additional tool: SignalP, which provides to exclude the signal 
peptide-bearing proteins from the dataset. Transportome based studies of 
mucosal pathogens can give rise to many new drug and vaccine targets for 
prophylactic and therapeutic interventions.  
Introduction And Background 
U.urealyticum is a human mucosal pathogen which derives almost all its 
energy from hydrolysis of urea. A member of the Mollicutes (mycoplasma) 
class, it is among the smallest-known free-living microorganisms [1, 64]. It 
belongs to the family of Mycoplasmas and is noteworthy because of the small 
size of its cells (0.2 to 0.3 micrometers) and of its genome (.75 Mb) [2]. This 
feature is largely responsible for its biologic properties, including lack of a Gram 
stain reaction and nonsusceptibility to many commonly prescribed antimicrobial 
agents, including beta-lactams. It belongs to the family of organisms which are 
usually associated with mucosae and mucosal membranes [64]. They reside 
extracellularly in the respiratory and urogenital tracts and rarely penetrate the 
submucosa, except in the case of immunosuppression or instrumentation, 
when they may invade the bloodstream and disseminate to numerous organs 
and tissues [60]. Ureaplasma species are the most common nonbacterial 
etiologies of infectious arthritis in persons who are hypogammaglobulinemic [2, 
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58, 60]. In several large studies, chronic lung disease of prematurity or 
bronchopulmonary dysplasia has also been associated with the presence of 
Ureaplasma organisms in the lower respiratory tract, presumably because of 
low-grade inflammation in the airways that causes a prolonged need for 
supplemental oxygen coupled with barotrauma of mechanical ventilation and 
oxidant damage due to oxygen administration [60]. It has also been identified as 
one of the causes of intrauterine-mediated diseases in newborns [60].  
Reductive evolution of the genome seems to have occurred several times 
and to have been very rapid [3, 4, 65]. Because of its reduced genome size, and 
also its clinical [5] and veterinary importance, it has received much attention 
from sequencing centers. The genome of U. urealyticum serovar 3 is a circular 
chromosome comprising 751,719 bp. This is smaller than any other sequenced 
microbial genome except M. genitalium [6]. The G+C content is 25.5%. The 
genome contains 614 predicted protein-coding genes and 39 genes that code 
for RNAs. The genes comprise 93% of the genome. 53% of the protein-coding 
genes have been assigned biological roles. 19% of the genes are similar to 
hypothetical genes of unknown function, and 28% are unique hypothetical 
genes with no significant similarities to putative or demonstrated genes in other 
organisms [3, 4 ,5, 6].  
The reduction in size of the Ureaplasma genome is thought to be related to 
its lifestyle, in close contact with their host [3, 6, 60, 65]. Ureaplasmas are either 
commensals or pathogens, and sometimes are facultative intracellular 
parasites [3, 4, 5]. The adoption of a parasitic life style, based on harnessing the 
resources of the host cell, means that numerous metabolic functions are no 
longer needed [58, 65]. It synthesizes indeed few precursors de novo, and the 
loss of genes for numerous biosynthetic pathways has been noted in the 
genomes of the mycoplasmas that have been sequenced to date. Ureaplasmal 
infections have been proved to have serious metabolic consequences. The loss 
of the cell wall may also be related to intracellular endoparasitism [58].  
There are no genes for the de novo biosynthesis of purines or pyrimidines in 
U.urealyticum. Pathways for synthesis of RNA and DNA precursors are absent 
as is evidently shown by several notable missing enzymes [65, 66]. For example, 
there is no recognizable ribonucleoside-diphosphate reductase for conversion 
of ribonucleosides to deoxyribonucleosides, unlike in M. genitalium and M. 
pneumoniae [59, 64]. So U.urealyticum must import all its deoxyribonucleosides 
and/or deoxyribonucleoside precursors, or have a mechanism for converting 
ribonucleosides to deoxyribonucleosides [23, 25, 26]. As a result of its very limited 
biosynthetic capacity, ureaplasmas must import more of the nutrients needed 
for growth than do most other bacteria [26, 58, 65]. 30 different U.urealyticum 
transporters have been identified, which represent many transporter families. 
Despite this diversity of transport systems, there are a number of surprising 
absences, such as the previously mentioned lack of transporters for bases, 
nucleotides, nickel and urea [58, 65]. Missing transporters may be found among 
the hypothetical U.urealyticum proteins that have 5 or more predicted 
Page 3 of 25The Transportome of the Human Mucosal Pathogen Ureaplasma urealyticum
8/31/2007http://www.lurj.org/article.php/vol2n1/ureaplasma.xml
transmembrane regions. We have utilized five different tools to predict the 
proteins with transmembrane segments and domains. In this paper, we follow 
an approach aimed at identifying the genes and/or gene products involved in 
transporter-related functions in U.urealyticum. The Transport Classification (TC) 
system [7] represents a systematic approach to organize transport systems 
according to the mode of transport, energy-coupling mechanism [29], molecular 
phylogeny and substrate specificity. Based on TC system, Transport database- 
a relational database is designed for describing the cellular membrane 
transport proteins in organisms whose complete genome sequences are 
available [8]. Transport systems allow the uptake of essential nutrients and ions, 
excretion of end products of metabolism and deleterious substances, and 
communication between cells and the environment [9, 25, 58]. They also provide 
essential constituents of energy-generating and energy-consuming systems [10, 
23, 26, 29,62]. Primary active transporters drive solute accumulation or extrusion by 
using ATP hydrolysis, photon absorption, electron flow, substrate 
decarboxylation, or methyl transfer [11, 25, 26, 62]. If charged molecules are 
unidirectionally pumped as a consequence of the consumption of a primary 
cellular energy source, electrochemical potentials result [10, 62, 68]. The 
consequential chemiosmotic energy generated can then be used to drive the 
active transport of additional solutes via secondary carriers which merely 
facilitate the transport of one or more molecular species across the membrane 
[12, 13, 25]. 
Methods 
Identification and Classification of Transporter proteins 
The completed genome and protein table for U.urealyticum strain were 
accessed from the NCBI ftp site (ftp://ftp.ncbi.nlm.nih.gov/genomes/). We 
followed the approach of Kiranmayi and Mohan, in which a stepwise procedure 
was used to screen out targets. All the ORFs identified in the U.urealyticum 
genome were BLAST searched against the Swiss-Prot/TrEMBL database and 
only functionally characterized proteins were taken into account. All the 
transporter protein coding genes were classified according to the Transporter 
Database ( [www.membranetransport.org/ ... ] ). The transmembrane domains 
were obtained using TOPPRED ( [ bioweb.pasteur.fr/seqanal/inter ... ] ) 
software which is based on the Kyte-Doolittle scale of hydrophobicity [14] and 
Positive-inside rule. The roles played by these transporters in various 
biochemical and metabolic pathways were confirmed by checking for their 
presence in the U.urealyticum pathways registered in the Kyoto Encyclopedia 
of Genes and Genomes Database (KEGG) 
( [www.genome.jp/kegg/pathway.html ... ] ). Domain searches for the 
transporter proteins were carried out using the Pro Dom server 
( [prodom.prabi.fr/prodom/current/h ... ] ) and Pfam 
( [www.sanger.ac.uk/Software/Pfam/ ... ] ). Phylogenetic analysis was 
performed using TREETOP software 
( [www.genebee.msu.su/services/phtr ... ] ) and trees were bootstrapped 100 
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times to ensure the reliability of each branch point [21]. 
Analyses of Hypothetical proteins 
The hypothetical proteins, inclusive of unique putative membrane 
lipoproteins and conserved hypothetical proteins from the U.urealyticum 
genome were analyzed for the presence of transmembrane signatures using 
online tools like HMMTOP ( [www.enzim.hu/hmmtop/] ) [15], SOSOI 
( [sosui.proteome.bio.tuat.ac.jp/so ... ] ) [16], TopPred II 
( [www.sbc.su.se/~erikw/toppred2/ ... ] ), [17] and TMHMM 
( [www.cbs.dtu.dk/services/TMHMM-2. ... ] ) [18] available through the Expasy 
server. In addition, another tool called wave TM 
( [athina.biol.uoa.gr/bioinformatic ... ] ) [19] was also used for the prediction of 
transmembrane signatures. Proteins predicted to contain transmembrane 
segments by TMHMM, HMMTOP, SOSUI, TopPred and WaveTM were tested 
further using SignalP version 3.0 ( [www.cbs.dtu.dk/services/SignalP/ ... ] ), [20]. 
Default conditions were used for the predictive analyses. A positive prediction 
of signal peptides by SignalP was considered to start within the first 70 amino 
acids of the N-termini of the proteins.  
Results and Discussion 
Characterizing the Transporter Dataset 
We have identified 67 (inclusive of subunits of individual transporters) 
transporters by integrated computer based analysis of the Ureaplasma 
proteins. These transporters fall into various categories involved in the transport 
of many metabolites and nutrients, among which some of them are those 
transporting aminoacids, polypeptides, deoxyribonucleosides and/or 
deoxyribonucleoside precursors, and inorganic metal ions of cobalt, copper, 
iron, potassium, and magnesium which function as cofactors for many enzymes 
[FIGURE 1]. The transporters are placed in their respective families according 
to the TC system of classification based on characteristic features like 
transmembrane domains, hydropathic plots, conserved motifs/ residues and 
molecular phylogeny. All the 67 transporter protein-related ORFs which have 
been identified are summarized in TABLE 1. The homologs of the Ureaplasma 
transporters in other prominent bacterial pathogens are summarized in TABLE 
2.  
Figure 1: Schematic representation of the Ureaplasma urealyticum 
transporter protein classification  
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Table 1: Transporter genes of Ureaplasma urealyticum. ABC: ATP 
Binding Cassette, VIC: Voltage Gated Ion Channel, GPTS: General 
Phosphotransferase System, SSPTS: Sugar Specific Phosphotransferase 
System, AMT: Ammonium Transporter, APC: Amino acid – Polyamine 
Organocation, MOP: Multidrug/oligosaccharidyl-lipid/ Polysaccharide, 
OXA: Cytochrome Oxidase Biogenesis, MGTE: Mg 2+ ion Transporter E.  
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Table 2: Homology levels of the Ureaplasma urealyticum transporters 
with respect to their counterparts in prominent bacterial pathogens. The 
values indicate how much the transporter proteins have diverged from or 
converged towards the representative species  
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F-ATPase Enzyme Complex 
U.urealyticum lacks the conventional mechanisms for adenosine 5-
triphosphate (ATP) generation, such as glycolysis or arginine breakdown, 
present in other mycoplasmas. The energy yielding ATP molecules are 
generated through the formation of an ion gradient coupled to urea hydrolysis 
[23, 26, 67]. U. urealyticum contains an enzyme complex involved in energy 
production via proton efflux. This family of enzymes, belonging to the functional 
class of energy metabolism and ATP-proton motive force interconversion 
comprises two oligomeric complexes: F1 - the catalytic core and FO - the 
membrane proton channel. F1 has five subunits: Alpha(3), Beta(3), Gamma(1), 
Delta(1) and Epsilon(1) [62, 67]. FO has three main subunits: A, B and C [22, 26, 67]. 
The ureaplasma subunit of the F1 complex, which in other organisms is the 
interface between the FO and F1 subunits and causes the permeability of the 
transmembrane proton channel FO, is present as two distinct peptides [67]. 
UU134 corresponds to the two-thirds of the amino-terminal of the eubacterial 
consensus, and UU133 corresponds to the normally more conserved carboxyl 
terminus. This non-paralogous gene cluster (UU053, UU054, UU128-UU130, 
and UU132-UU137) is a likely candidate for the ATP synthase activity seen in 
conjunction with the urease present in Ureaplasma urealyticum. Speculatively, 
these atypical features may be linked to the unique ATP production pathways 
of ureaplasmas [62]. The source for 5% of ureaplasma ATP production resulting 
from urea hydrolysis are most probably from substrate phosphorylation [22]. 
Enzymatic studies show that U. urealyticum has a limited capacity to 
metabolize carbohydrates [22, 23, 26].  
Bacterial F-type ATPases pump 3-4 H + and Na + out of the cell per ATP 
hydrolyzed [67]. These enzymes also operate in the opposite direction, 
synthesizing ATP when protons flow through the 'ATP synthase' down the 
proton electrochemical gradient (the 'proton motive force' or pmf) [26, 68]. V-type 
ATPases may pump 2-3 H + per ATP hydrolyzed, and these enzymes cannot 
catalyze pmf-driven ATP synthesis. It has been proposed that this difference 
between F-type and V-type ATPases is due to a 'proton slip' that results from 
an altered structure in the membrane sector of V-type ATPases [68]. It has also 
been shown that the Ureaplasma's membrane bound ATPase enzyme complex 
has similarities to the FO F1 ATPases of other bacteria [23, 25, 62, 67]. It has also 
been reported that ATP determination represents a reliable and accurate 
means of measuring growth [24]. It is therefore attractive to propose that an FO 
F1 membrane ATPase in U.urealyticum plays an important role in energy 
generation [62]. This could in turn rely upon a chemiosmotic mechanism [25, 26], 
whereby generation of a transmembrane electrochemical potential would 
provide the electrochemical force for protons to enter the cell via the FO F1 
membrane ATPase to generate ATP [67]. Such electrochemical potentials may 
also be used in transport processes. It has been suggested that since 
U.urealyticum has a potent cytosolic urease, urea hydrolysis to ammonium ions 
and carbon dioxide generates a transmembrane potential which drives ATP 
synthesis [26, 58, 61, 69]. It is worth mentioning that the pH of the urogenital tract is 
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usually on the acidic side of neutrality, corresponding to the pH values 
optimal for ureaplasma growth, maximum increase in delta P, maximum 
ammonia chemical potential, maximum urease activity, and maximum ATP 
generation [25, 26]. Hence targeting the components of this indispensable energy 
generating system of Ureaplasma would be a good option to block growth and 
multiplication.  
Iron transporters 
Unexpected among the 19 ABC transporters are many different Fe 3+ and/or 
haemin transporters. Iron is essential for the function of many enzymes [29]. 
However, the low solubility of Fe 3+ at physiological pH forces Ureaplasma 
urealyticum to develop special mechanisms to acquire necessary amounts. 
Phylogenetic analysis of the ten membrane-spanning protein subunits (UU070, 
UU025, UU023, UU022, UU516, UU515, UU358, UU357, UU399, and UU400) 
of the U. urealyticum iron transporters indicated that they all cluster together 
with respect to other known bacterial proteins [FIGURE 2] and form two related, 
but distinct paralogous groups within this U. urealyticum gene family [FIGURE 
3]. Except for UU399 which has 8 membrane spanners, all the other iron 
transporters are characterized by the presence of 9 transmembrane segments 
in the N-terminus. This paralogous family arose from gene duplication events 
during ureaplasma evolution [70, 71]. In the apparent absence of the complement 
of transcriptional regulators found in most other bacteria, it is speculated that U. 
urealyticum increased its capacity to import iron by increasing the number of 
iron transporter genes [70]. This indicates that the availability of iron may be a 
limiting factor of ureaplasma growth [29, 71]. Iron is associated with the 
membranes of Mycoplasma capricolum [ 27 ] and M. pneumoniae [28]. In these 
mycoplasmas, the iron may act as a reversible electron carrier in concert with 
NADH oxidase, or as a component of an iron-containing electron storage 
protein [28]. Unlike the other mycoplasmas, U. urealyticum lacks both NADH 
oxidase activity [29] and an NADH oxidase gene. Even if ureaplasmas use iron 
in their respiration, the iron use is probably different from that in other 
mycoplasmas [27, 28, 70]. 
Figure 2: Phylogeny of the membrane spanning subunits of the ten 
iron transporters of Ureaplasma urealyticum with respect to iron 
transporting genes of other pathogens  
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Figure 3: Phylogenetic representation of the paralogous nature of the 
iron transporters in Ureaplasma urealyticum. The tree shows the two 
paralogous groups of iron transporters, most of which are copies of one 
essential parent iron-transporter gene  
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MOP MATE Family 
The MOP flippase superfamily includes four distantly related families, 
among which is the ubiquitous family (MATE) specific for drugs. All functionally 
characterized members of the MOP superfamily catalyze efflux of their 
substrates, presumably by cation antiport [78]. The MATE family includes a 
functionally characterized multidrug efflux system from Vibrio parahaemolyticus 
NorM [30, 31, 78], and several homologues from other closely related bacteria 
(including U.urealyticum) that function by a drug:Na + antiport mechanism. 
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Some of the other members of this family include a putative methionine 
resistance protein of Saccharomyces cerevisiae, a cationic drug efflux pump in 
A. thaliana [32] and the functionally uncharacterized DNA damage-inducible 
protein F (DinF) of E. coli [33, 34, 78]. In Ureaplasma, there are two paralogous 
proteins (UU583 and UU584) of this family. These are of about 450 amino acyl 
residues in length and exhibit 12 putative TMS. They arose by an internal gene 
duplication event from a primordial 6 TMS encoding genetic element. The yeast 
proteins are larger (upto about 700 residues) and exhibit about 12 TMSs. The 
family includes hundreds of functionally uncharacterized but sequenced 
homologues from bacteria, archaea, and all eukaryotic kingdoms. The 
members of this family in Ureaplasma can be used as very efficient and 
effective targets in co-drug therapies. Protein domain searches show that 
residues 165-298 are 26% similar to a defined domain of O34474_BACSU, a 
virulence factor.  
Ammonium Transporters 
U. urealyticum generates 95% of its ATP through the hydrolysis of urea by 
urease [22]. Since the discovery in 1966 that ureaplasmas metabolize urea, the 
physiology of this energetic process has been studied to gain an understanding 
of what appears to be a unique system [35, 61]. The hypothesis is that hydrolysis 
of urea generates an electrochemical gradient through the accumulation of 
intracellular ammonia/ammonium [61]. This gradient fosters a chemiosmotic 
potential that generates ATP. The intracellular concentration of ammonia 
generated through urea hydrolysis in U. urealyticum has been measured to be 
21 times the extracellular concentration [63]. This excess suggests efflux of 
ammonium/ammonia through a saturable uniporter rather than by passive 
diffusion [22, 61, 63]. A pair of paralogous genes that code for ammonia 
transporters of the Amt family were identified (UU218, UU219). Pfam searches 
place residues 48 to 463 of UU218 in the Ammonium Transporter Family 
(PF00909) [63]. Homologs occur in Gram-negative and Gram-positive bacteria, 
archaea, yeast, plants and animals and are probably ubiquitous. Although the 
physiology of Amt family transporters is controversial [36, 37, 38, 63], the probable 
mechanism in ureaplasma is energy-independent-facilitated diffusion [35, 61, 62]. 
The electrochemical gradient created by the export of ammonium presumably 
results in an ATP molecule generating proton influx through the U. urealyticum 
F-type ATPase. The proteins of the Amt family vary in size from 391 to 622 
amino acyl residues and possess 11 (N-terminus out; most members) or 12 (N-
terminus in) transmembrane α-helical spanners. Because of their channel-like 
properties, these proteins might more appropriately be classified in TC class 
1.A. However, because of several reports suggesting that some members 
exhibit carrier properties, the family is retained in class 2.A for the present.  
P-ATPase type cation transporters 
Nearly all of the members of this superfamily of P-ATPases, found in 
bacteria, archaea and eukaryotes, catalyze cation uptake and/or efflux driven 
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by ATP hydrolysis [79]. Most of these protein complexes are multisubunits 
with a large subunit serving the primary ATPase and ion translocation 
functions. The Ca2+ ATPase (UU264) reported as a paralog to UU203, 
catalyzes calcium ion antiport. A single organism may possess multiple 
isoforms of this protein entity [79]. Some members of the P-type ATPase family 
have been reported to flip phospholipids from one monolayer of the bilayer 
membrane to the other monolayer [39, 40, 79]. Protein Domain searches of the 
calcium ion transporter reveal that residues 8-179 are 36% similar to a defined 
domain of ATC_ARTSF, residues 262-353 are 55% similar to 
O59868_SCHPO, and residues 474-557 are 52% similar to ATCL_MYCGE, all 
of which are described as ATPase proteins. It is also characterized by the 
presence of about 16 transmembrane helices from the N- terminal region. The 
paralog, UU203, a copper ion transporting ATPase belongs to the functional 
class of cation transport and binding proteins [39]. As this sequence contains 
similarity to ATPases, and contains 11 transmembrane regions, it is possible 
that this represents an export protein [40]. Curiously, the closest domain comes 
from a yeast sequence: residues 233-463 are 33% similar to residues 478-717 
of ATU2_YEAST, a predicted P-type copper-transporting ATPase. 
VIC Potassium Channel Protein 
The K + channels usually consist of homotetrameric structures with each α-
subunit possessing six transmembrane spanners (TMSs). Many voltage-
sensitive K + channels function with β-subunits that modify K + channel gating 
[41]. These nonintegral β-subunits are oxidoreductases that co-assemble with 
the tetrameric α-subunits in the endoplasmic reticulum and remain tightly 
adherent to the α-subunit tetramer. The high resolution β-subunit structure is 
available [41]. Evolutionary relationships between K + channels and certain K 
+ :cation symporters has been reviewed and discussed [42]. It has been shown to 
form tetramers that may function to maintain the membrane potential in the 
early stationary phase of growth [43]. No paralogs have been found and protein 
domain searches show that residues 219-318 are 30% similar to a defined 
domain of O67715_AQUAE, an ion channel. 
The Amino Acid-Polyamine-Organocation transporters 
(APC) 
The APC superfamily of transport proteins includes members that function 
as solute:cation symporters and solute:solute antiporters [44]. They occur in 
bacteria, archaea, yeast, fungi, unicellular eukaryotic protists, slime molds, 
plants and animals [44]. They vary in length, being as small as 350 residues and 
as large as 850 residues. Most of them possess twelve transmembrane α-
helical spanners but have a re-entrant loop involving TMSs 2 and 3 [45]. The 2 
representatives (UU223 and UU579) of this family in U.urealyticum are non-
paralogous. Residues 28-100 of UU223 constitute a domain of XASA_ECOLI, a 
transmembrane amino acid permease. 
Page 15 of 25The Transportome of the Human Mucosal Pathogen Ureaplasma urealyticum
8/31/2007http://www.lurj.org/article.php/vol2n1/ureaplasma.xml
GPTS sugar transporter 
The Phosphoenolpyruvate-dependent Sugar PhosphoTransferase system 
(PTS) is a major carbohydrate transport system in Ureaplasma. The PTS 
catalyzes the phosphorylation of incoming sugar substrates concomitant with 
their translocation across the cell membrane. The general mechanism of the 
PTS is as follows: a phosphoryl group from phosphoenolpyruvate (PEP) is 
transferred to Enzyme I (EI) of the PTS which in turn transfers it to a phosphoryl 
carrier protein (HPr) [46, 72, 73]. Phospho-HPr then transfers the phosphoryl group 
to a sugar-specific permease complex (enzymes EII/EIII) [46, 73]. UU587, a 
phosphohistidinoprotein-hexose phosphotransferase, is the representative of 
this family of sugar transporters in U.urealyticum and thus plays a significant 
role in acquiring sugars required for growth and energy from the host [72, 74]. 
Residues 1 to 84 place UU587 in the PTS-HPr family which is described as 
PTS HPr component phosphorylation site (PF00381) according to Pfam. 
SSPTS sugar (glucose) transporter 
UU178 is another type of non paralogous transporter of sugars, especially 
glucose. SSPTS, as the name suggests, is a sugar specific transporter family 
found in many bacteria [73]. This Glc family includes porters specific for glucose, 
glucosamine, N-acetylglucosamine and a large variety of α- and β-glucosides. 
However, not all β-glucoside PTS porters are in this class, as the PTS porter 
first described as the cellobiose (Cel) β-glucoside porter is the 
diacetylchitobiose porter in the Lac family (TC #4.A.3). The IIA, IIB and IIC 
domains of all of the group translocators are demonstrably homologous [73, 75]. 
Several of the PTS porters in the Glc family lack their own IIA domains and 
instead use the glucose IIA protein (IIA glc or Crr). Most of these porters have 
the B and C domains linked together in a single polypeptide chain. A cysteyl 
residue in the IIB domain is phosphorylated by direct phosphoryl transfer from 
IIA glc (his~P) or one of its homologues [77]. Those porters which lack the IIA 
domain include the maltose (Mal), arbutin-salicin-cellobiose (ASC), trehalose 
(Tre), putative glucoside (Glv) and sucrose (Scr) porters of E. coli [74, 75]. Most, 
but not all Scr porters of other bacteria also lack a IIA domain. Residues 12-123 
are 35% similar to a defined domain of Y129_MYCGE [76, 77]. 
The Magnesium ion transporter 
Belonging to the functional class of cation transport and binding proteins, 
this ubiquitous transporter protein (UU009) has many sequenced homologs in a 
wide variety of bacteria, archaea and eukaryotes. Its phylogeny roughly follows 
that of the organismal taxonomies [48]. The homologs have sizes that vary 
considerably from 311 residues for the Methanococcus thermoautotrophicum 
protein, 463 residues for the Synechocystis homologue, and 513 residues for 
the human homolog, SLC41A1. The B. firmus transporter and several 
homologs examined have strongly charged, hydrophilic N-terminal domains 
(cytoplasmic) followed by a hydrophobic C-terminal domain with 5 putative 
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transmembrane α-helical spanners [48]. The central 100 residues resembles 
archaeal inositol monophosphate dehydrogenases [47]. The modes of transport, 
the nature of the energy source and the potential reversibility of the transport 
reaction have not been studied. However, the available evidence suggests that 
the MgtE proteins are secondary carriers with inwardly directed polarity [47, 48]. 
Residues 146-263 are 28% similar to an inosine-5'-monophosphate CBS 
domain as seen in YC32_METJA.  
Prediction of Transmembrane Segments in Hypothetical 
Proteins 
For the identification of transmembrane signatures in the hypothetical 
proteins of U.urealyticum, we have used a range of computational tools. The 
most primitive tools relied on the hydrophobicity of transmembrane helices [14]. 
The continuing development of additional strategies has improved their 
predictive accuracies. Some, for example, examine the whole amino acid 
sequence of a membrane protein [49, 50]. Such tools also search for the 
distribution of particular amino acids since, in general, the cytoplasmic side of 
integral membrane proteins is positively charged, a phenomenon known as the 
“positive-inside rule” [17]. A substantial improvement has been achieved with the 
utilization of hidden Markov model (HMM) algorithms [15]. However, a major 
pitfall of all methods is the erroneous prediction of the N-terminal signal 
peptides as transmembrane segments as a result of their hydrophobic nature. 
We utilized five different computational tools that are based on four different 
algorithm approaches in order to predict integral membrane proteins in the 
Ureaplasma proteome. The tools were: TopPred II, which scans proteins for 
hydrophobic stretches of amino acids and the inside-positive phenomenon; 
SOSUI, which examines a combination of amino acid hydrophobicity, 
amphiphilicity of the transmembrane segment, amino acid charges, and length 
of transmembrane segment; and TMHMM and HMMTOP, both of which are 
based on hidden Markov model algorithm. A newer method for predicting 
transmembrane segments, waveTM, was also utilized. WaveTM uses a 
mathematical function known as wavelet, which measures the hydrophobicity of 
a sliding 20-amino acid window.  
A total of 283 proteins of unknown function from the Ureaplasma proteome 
were subjected to this study. It was thought that the missing transporters can 
be found among the uncharacterized hypothetical proteins. SOSUI predicted 
the fewest integral membrane proteins (107 proteins or 37.80% of total protein 
set of 283); TopPred II predicted the largest number of proteins to contain 
membrane spanning segments (245 proteins or 86.57%). The other three 
programs estimated integral membrane proteins within this range with TMHMM 
predicting 112 proteins (39.57%), HMMTOP predicting 137 proteins (48.40%), 
and waveTM predicting 119 proteins (42.04%)[TABLE 3]. Almost half of the 
proteins classified as integral membrane proteins by TMHMM, SOSUI, 
HMMTOP and waveTM were predicted to contain a single transmembrane 
segment (53.37%, 48.59%, 50.36% and 51.26 % respectively). But TopPred II 
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predicted the fewest proteins with one transmembrane segment (29.38%). 
Prediction of proteins with 5 or more transmembrane segments was more 
coherent [TABLE 3]. The range of positive predictions for transmembrane 
proteins with 5 or more TMSs falls between 16.05% (HMMTOP) and 21.49% 
(SOSUI).  
Table 3: Analysis of the hypothetical proteins of Ureaplasma 
urealyticum using various tools to detect the presence of transmembrane 
signatures. P1 – Ratio based on the total number of hypothetical proteins 
taken for analysis (283). P2 – Ratio is calculated on the basis of the 
number of proteins predicted with transmembrane segments for each 
tool.  
 
 
In order to eliminate false-positive predictions, a sixth method, SignalP, 
which discriminates between signal peptides and transmembrane segments, 
has also been utilized. Due to the hydrophobic nature of signal peptides, all 
programs used in this study are susceptible for erroneous classification of 
signal peptides as transmembrane segments. Therefore, we tested for possible 
false-positive predictions among the proteins predicted to contain 
transmembrane segments using SignalP. This tool combines two computational 
methods, namely neural networks and hidden Markov model, to predict the 
presence of signal peptides based on amino acid composition and cleavage 
site of signal peptides. After removing the false positives by SignalP, we can 
conclude that TMHMM has predicted 73 proteins, SOSUI 88 proteins, 
HMMTOP 115 proteins, TopPred 235 proteins and waveTM 89 proteins as 
positive predictions or in other words hypothetical proteins which have been 
predicted to be non-secretory and hence integral to the membrane. These 
predictions constituted 25.79%, 31.09%, 40.63%, 83.03% and 31.44% of all the 
hypothetical proteins tested (283), respectively [TABLE 4]. 
Table 4: Final prediction of non-secretory transmembrane proteins 
among the hypothetical proteins in Ureaplasma urealyticum using 
SignalP. P1 – Ratio based on the total number of hypothetical proteins 
taken for analysis (283). P2 – Ratio is calculated on the basis of the 
number of proteins predicted with transmembrane segments for each 
tool. P3 – Ratio is calculated on the basis of the number of proteins 
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predicted with single transmembrane segment for each tool. P4 – 
Ratio is calculated on the basis of the number of proteins predicted with 
single transmembrane segments in the first 70 amino acids.  
 
Membrane transporters as drug targets 
Comparative analysis of complete genomes revealed that most of the 
pathogens have drastically diminished biosynthetic capabilities as compared to 
their free-living relatives [51, 52]. Instead, these organisms depend on their hosts 
to provide essential nutrients such as amino acids, nucleobases, and vitamins. 
Transport systems for these nutrients are generally well conserved and easily 
identifiable [53]. Analysis of metabolic pathways allows one to predict which 
substrates cannot be produced inside the cells and so need to be transported 
[54]. All this makes bacterial transport proteins attractive drug targets. A number 
of non-metabolizable analogs of amino acids and nucleobases are already 
available and can be easily checked for their potential antibacterial activity. 
Finally, an interesting approach that has emerged only recently includes 
improving activity of the existing antibiotics by inhibiting bacterial multidrug 
transporters [52]. Genomes of many pathogenic bacteria appear to contain 
homologs of multidrug pumps, such as MOPMATE protein in U.urealyticum, 
which protects bacterial cells by exporting antibiotic molecules. Inhibiting such 
pumps not only creates convenient model organisms for studying drug 
effectiveness [56] but also allows resistance to classical drugs such as 
tetracycline to be overcome [57]. The nearly universal distribution of most major 
classes of transport proteins [55], however, makes it probable that effective 
inhibitors of bacterial transport turn out to be also toxic for humans. So we must 
sort out those essential transporters which have no significant homologs in 
humans as the most probable and suitable drug targets. Extracellular subunits 
of these transporters can also be used as vaccine targets.  
Conclusion 
Mucosal pathogens like those in the mycoplasmal family predominantly rely 
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on the host for nutrient supply as they have lost many of the genes or 
genetic clusters coding for biosynthetic pathways, thus making these pathways 
incomplete or obsolete. As a result, transporter proteins are so critical for the 
pathogens' survival and multiplication. The availability of the genome sequence 
of U.urealyticum has helped in the primary identification of transporter genes. 
Proteomics also holds good potential to achieve biomedical milestones in many 
disciplines, in particular the discovery of drug targets. Choosing an optimal 
target function is a crucial step in the long and expensive process of drug 
development and requires the best possible understanding of related biological 
processes in bacterial pathogens and their hosts. A class of proteins of special 
interest is transmembrane proteins. The significance of these proteins is that 
they constitute more than 45% of current drug targets. Ureaplasma has been 
found to encode more transporters than other members of the mycoplasma 
family. The presence of two paralogous groups of iron transporters in 
Ureaplasma suggests that gene duplication has occurred and that iron is very 
essential for so many activities of this deadly emerging pathogen [70]. 
Ammonium transporters are yet another class of transporters which are very 
essential to Ureaplasma as they are involved in the creation of the 
electrochemical gradient by the export of ammonia, which therefore results in 
ATP generation. In addition, there is an array of transporters ranging from the 
ABC subtypes involved in cation transport to the drug efflux pumps. Advanced 
biochemical characterization and laboratory studies will give rise to much 
important information about the efficacy of using these transporter proteins as 
drug targets.  
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